Propagation of Tau Pathology in a Model of Early Alzheimer's Disease

de Calignon, Alix, Polydoro, Manuela, Suárez-Calvet, Marc, William, Christopher, Adamowicz, David H., Kopeikina, Kathy J., Pitstick, Rose, Sahara, Naruhiko +4 more·2012·Neuron

Cited by (1,003)

Items 301–400 of 1,003

  1. Potential Contribution of Exosomes to the Prion-Like Propagation of Lesions in Alzheimer’s Disease
    Vingtdeux, Valérie, Sergeant, Nicolas, Buée, Luc · 2012 · Frontiers in Physiology
  2. Spreading of α-Synuclein and Tau: A Systematic Comparison of the Mechanisms Involved
    Eftychia Vasili, Antonio Dominguez‐Meijide, Tiago F. Outeiro · 2019 · Frontiers in Molecular Neuroscience
  3. Synaptic tau: A pathological or physiological phenomenon?
    Miranda Robbins, Emma L. Clayton, Gabriele S. Kaminski Schierle · 2021 · Acta Neuropathologica Communications
  4. β‐Amyloid is transmitted via neuronal connections along axonal membranes
    Ha‐Lim Song, Sungbo Shim, Dong‐Hou Kim, Sehoon Won, Segyeong Joo, Sudong Kim, Noo Li Jeon, Seung‐Yong Yoon · 2013 · Annals of Neurology
  5. Degradation and Transmission of Tau by Autophagic-Endolysosomal Networks and Potential Therapeutic Targets for Tauopathy
    Shanya Jiang, Kiran Bhaskar · 2020 · Frontiers in Molecular Neuroscience
  6. Repeat associated non-ATG (RAN) translation: new starts in microsatellite expansion disorders
    John Douglas Cleary, Laura P.W. Ranum · 2014 · Current Opinion in Genetics & Development
  7. Studying synapses in human brain with array tomography and electron microscopy
    Kevin R. Kay, Colin Smith, Ann K. Wright, Alberto Serrano‐Pozo, Amy M. Pooler, Robert M. Koffie, Mark E. Bastin, Thomas H. Bak, Sharon Abrahams, Katherine J. Kopeikina et al. · 2013 · Nature Protocols
  8. 3‐O‐Sulfation of Heparan Sulfate Enhances Tau Interaction and Cellular Uptake
    Jing Zhao, Yanan Zhu, Xuehong Song, Yuanyuan Xiao, Guowei Su, Xinyue Liu, Zhangjie Wang, Yongmei Xu, Jian Liu, David Eliezer et al. · 2019 · Angewandte Chemie International Edition
  9. Tau deposition patterns are associated with functional connectivity in primary tauopathies
    Nicolai Franzmeier, Matthias Brendel, Leonie Beyer, Luna Slemann, Gábor Géza Kovács, Thomas Arzberger, Carolin Kurz, Gesine Respondek, Milica Ječmenica‐Lukić, Davina Biel et al. · 2022 · Nature Communications
  10. Demyelination precedes axonal loss in the transneuronal spread of human neurodegenerative disease
    Yuyi You, Chitra Joseph, Chenyu Wang, Vivek Gupta, Sidong Liu, Con Yiannikas, Brian Chua, Nitin Chitranshi, Ting Shen, Yogita Dheer et al. · 2018 · Brain
  11. Glial Tau Pathology in Tauopathies: Functional Consequences
    Martha A. Kahlson, Kenneth J. Colodner · 2015 · Journal of Experimental Neuroscience
  12. Recent therapeutic strategies targeting beta amyloid and tauopathies in Alzheimer's disease
    Yamini Madav, Sarika Wairkar, Bala R. Prabhakar · 2019 · Brain Research Bulletin
  13. Synaptic Amyloid-β Oligomers Precede p-Tau and Differentiate High Pathology Control Cases
    Tina V. Bilousova, Carol A. Miller, Wayne W. Poon, Harry V. Vinters, María M. Corrada, Claudia H. Kawas, Eric Y. Hayden, David B. Teplow, Charles G. Glabe, Ricardo Albay et al. · 2015 · American Journal Of Pathology
  14. Copper and Alzheimer’s Disease
    Zoe K. Mathys, Anthony Robert White · 2017 · Advances in neurobiology
  15. Antibody semorinemab reduces tau pathology in a transgenic mouse model and engages tau in patients with Alzheimer’s disease
    Gai Ayalon, Seung-Hye Lee, Oskar Adolfsson, Corinne Foo‐Atkins, Jasvinder K. Atwal, Mira Blendstrup, Helen S. Booler, Joseph Bravo, Robert P. Brendza, Flávia Brunstein et al. · 2021 · Science Translational Medicine
  16. Spreading of tau pathology in A lzheimer's disease by cell‐to‐cell transmission
    Nguyen‐Vi Mohamed, Thibaut Herrou, Vanessa Plouffe, Nicolas Piperno, Nicole M. Leclerc · 2013 · European Journal of Neuroscience
  17. Exosomes function in cell–cell communication during brain circuit development
    Pranav Sharma, Lucio Schiapparelli, Hollis T. Cline · 2013 · Current Opinion in Neurobiology
  18. Toward the Treatment and Prevention of Alzheimer's Disease: Rational Strategies and Recent Progress
    Gandy, Sam, DeKosky, Steven T. · 2013 · Annual Review of Medicine
  19. Tau biology, tauopathy, traumatic brain injury, and diagnostic challenges
    Castellani, Rudy J., Perry, George · 2019 · Journal of Alzheimer’s Disease
  20. Relationships between default-mode network connectivity, medial temporal lobe structure, and age-related memory deficits
    Andrew M. Ward, Elizabeth C. Mormino, Willem Huijbers, Aaron P. Schultz, Trey Hedden, Reisa Anne Sperling · 2014 · Neurobiology of Aging
  21. Alzheimer disease therapeutics: Focus on the disease and not just plaques and tangles
    Khalid Iqbal, Fei Liu, Cheng‐Xin Gong · 2014 · Biochemical Pharmacology
  22. Different tau species lead to heterogeneous tau pathology propagation and misfolding
    Dujardin, Simon, Bégard, Séverine, Caillierez, Raphaëlle, Lachaud, Cédrick, Carrier, Sébastien, Lieger, Sarah, Gonzalez, Jose A., Deramecourt, Vincent, Déglon, Nicole, Maurage, Claude-Alain et al. · 2018 · Acta Neuropathologica Communications
  23. Functional Disintegration of the Default Mode Network in Prodromal Alzheimer’s Disease
    Kim N. H. Dillen, Heidi I.L. Jacobs, Juraj Kukolja, Nils Richter, Boris von Reutern, Oezguer A. Onur, Karl‐Josef Langen, Gereon R. Fink · 2017 · Journal of Alzheimer s Disease
  24. Biomolecular Assemblies: Moving from Observation to Predictive Design
    Corey J. Wilson, Andreas Sebastian Bommarius, Julie A. Champion, Yury O. Chernoff, David G. Lynn, Anant K. Paravastu, Liang Chen, Ming-Chien Hsieh, Jennifer M. Heemstra · 2018 · Chemical Reviews
  25. Metformin attenuates plaque-associated tau pathology and reduces amyloid-β burden in APP/PS1 mice
    Chen, Yanxing, Zhao, Shuai, Fan, Ziqi, Li, Zheyu, Zhu, Yueli, Shen, Ting, Li, Kaicheng, Yan, Yaping, Tian, Jun, Liu, Zhirong et al. · 2021 · Alzheimer's Research & Therapy
  26. A novel tau‐based rhesus monkey model of Alzheimer's pathogenesis
    Danielle Beckman, Paramita Chakrabarty, Sean P. Ott, Amanda Dao, Eric Zhou, William G.M. Janssen, Kristine Donis‐Cox, Scott Muller, Jeffrey H. Kordower, John H. Morrison · 2021 · Alzheimer s & Dementia
  27. Prions and the Potential Transmissibility of Protein Misfolding Diseases
    Allison Kraus, Bradley R. Groveman, Byron W. Caughey · 2013 · Annual Review of Microbiology
  28. Amyloid β-Exposed Human Astrocytes Overproduce Phospho-Tau and Overrelease It within Exosomes, Effects Suppressed by Calcilytic NPS 2143—Further Implications for Alzheimer's Therapy
    Anna Chiarini, Ubaldo Armato, Emanuela Gardenal, Li Gui, Ilaria Dal Prà · 2017 · Frontiers in Neuroscience
  29. Tau covariance patterns in Alzheimer's disease patients match intrinsic connectivity networks in the healthy brain
    Rik Ossenkoppele, Leonardo Iaccarino, Daniel R. Schonhaut, Jesse A. Brown, Renaud La Joie, James P. O’Neil, Mustafa Janabi, Suzanne L. Baker, Joel H. Kramer, Maria‐Luisa Gorno‐Tempini et al. · 2019 · NeuroImage Clinical
  30. Deep learning detection of informative features in tau PET for Alzheimer’s disease classification
    Taeho Jo, Kwangsik T. Nho, Shannon L. Risacher, Andrew J. Saykin, Alzheimer’s Disease Neuroimaging Initiative · 2020 · BMC Bioinformatics
  31. Tau passive immunization blocks seeding and spread of Alzheimer hyperphosphorylated Tau-induced pathology in 3 × Tg-AD mice
    Dai, Chun-ling, Hu, Wen, Tung, Yunn Chyn, Liu, Fei, Gong, Cheng-Xin, Iqbal, Khalid · 2018 · Alzheimer's Research & Therapy
  32. Human iPSC-derived neuronal model of Tau-A152T frontotemporal dementia reveals tau-mediated mechanisms of neuronal vulnerability
    Silva, M. Catarina, Cheng, Chialin, Mair, Waltraud, Almeida, Sandra, Fong, Helen, Biswas, M. Helal U., Zhang, Zhijun, Huang, Yadong, Temple, Sally, Coppola, Giovanni et al. · 2016 · Stem Cell Reports
  33. Targeting of Monomer/Misfolded SOD1 as a Therapeutic Strategy for Amyotrophic Lateral Sclerosis
    H.-N. Liu, Sonja Tjostheim, K. DaSilva, D. Taylor, Beibei Zhao, Rishi Rakhit, M. Brown, Avijit Chakrabartty, JoAnne McLaurin, J. Robertson · 2012 · Journal of Neuroscience
  34. Tau-Based Therapeutics for Alzheimer’s Disease: Active and Passive Immunotherapy
    Francesco Panza, Vincenzo Solfrizzi, Davide Seripa, Bruno Pietro Imbimbo, Madia Lozupone, Andrea Santamato, Rosanna Tortelli, Ilaria Galizia, Camilla Prete, Antonio Daniele et al. · 2016 · Immunotherapy
  35. Defective lysosomal proteolysis and axonal transport are early pathogenic events that worsen with age leading to increased APP metabolism and synaptic Abeta in transgenic APP/PS1 hippocampus
    M. Torres, Sebastián Jiménez, Raquel Maria Sanchez-Varo, Victoria Navarro, Laura Trujillo‐Estrada, Elisabeth Sánchez‐Mejías, Irene Carmona, José Carlos Dávila, Marisa Vizuete, Antonia Gutiérrez et al. · 2012 · Molecular Neurodegeneration
  36. Discovery of Highly Selective and Nanomolar Carbamate-Based Butyrylcholinesterase Inhibitors by Rational Investigation into Their Inhibition Mode
    Edgar Sawatzky, Sarah Wehle, Beata Kling, Jan Wendrich, Gerhard Bringmann, Christoph Sotriffer, Jörg Heilmann, Michael W. Decker · 2016 · Journal of Medicinal Chemistry
  37. Cellular Prion Protein Mediates the Disruption of Hippocampal Synaptic Plasticity by Soluble TauIn Vivo
    Tomáš Ondrejčák, Igor V. Klyubin, Grant T. Corbett, Graham Mathew Fraser, Wei Hong, Alexandra J. Mably, Matthew J. Gardener, Jayne Hammersley, Michael S. Perkinton, Andrew Billinton et al. · 2018 · Journal of Neuroscience
  38. TIA1 regulates the generation and response to toxic tau oligomers
    Lulu Jiang, Peter E.A. Ash, Brandon F. Maziuk, Heather I. Ballance, Samantha Boudeau, Ali Al Abdullatif, Marcello Orlando, Leonard Petrucelli, Tsuneya Ikezu, Benjamin L. Wolozin · 2018 · Acta Neuropathologica
  39. Possible Mechanisms of Tau Spread and Toxicity in Alzheimer’s Disease
    Huiqin Zhang, Yu Cao, Lina Ma, Yun Wei, Hao Li · 2021 · Frontiers in Cell and Developmental Biology
  40. Alzheimer’s Disease: Mechanism and Approach to Cell Therapy
    Takashi Amemori, Pavla Jendelová, Jiří Růžička, Lucia Machová Urdzíková, Eva Syková · 2015 · International Journal of Molecular Sciences
  41. Long-term treadmill exercise attenuates tau pathology in P301S tau transgenic mice
    Odochi Ohia-Nwoko, Saghi Montazari, Yuen‐Sum Lau, Jason L. Eriksen · 2014 · Molecular Neurodegeneration
  42. Prion-like Spreading in Tauopathies
    Jacob I. Ayers, Benoit I. Giasson, David Borchelt · 2017 · Biological Psychiatry
  43. Axonal degeneration in tauopathies: disease relevance and underlying mechanisms
    Kneynsberg, Andrew, Combs, Benjamin, Christensen, Kyle, Morfini, Gerardo, Kanaan, Nicholas M. · 2017 · Frontiers in Neuroscience
  44. Anti-tau antibody administration increases plasma tau in transgenic mice and patients with tauopathy
    Yanamandra, Kiran, Patel, Tirth K., Jiang, Hong, Schindler, Suzanne, Ulrich, Jason D., Boxer, Adam L., Miller, Bruce L., Kerwin, Diana R., Gallardo, Gilbert, Stewart, Floy et al. · 2017 · Science Translational Medicine
  45. Optogenetic dissection of ictal propagation in the hippocampal–entorhinal cortex structures
    Yi Lu, Cheng Zhong, Lulu Wang, Pengfei Wei, Wei He, Kang Huang, Yi Zhang, Yang Zhan, Guoping Feng, Liping Wang · 2016 · Nature Communications
  46. Filamentous recombinant human Tau activates primary astrocytes via an integrin receptor complex
    Wang, Peng, Ye, Yihong · 2021 · Nature Communications
  47. Specific Calpain Inhibition by Calpastatin Prevents Tauopathy and Neurodegeneration and Restores Normal Lifespan in Tau P301L Mice
    Mala V. Rao, Mary Kate McBrayer, J. Campbell, Ashok Kumar, Ali Talib Hashim, Henry W. Sershen, Philip H. Stavrides, Masuo Ohno, Mike Hutton, Ralph A. Nixon · 2014 · Journal of Neuroscience
  48. Brain pathology in myotonic dystrophy: when tauopathy meets spliceopathy and RNAopathy
    Marie‐Laure Caillet‐Boudin, Francisco-José Fernández-Gómez, Hélène Tran, Claire‐Marie Dhaenens, Luc Buée, Nicolas Sergeant · 2014 · Frontiers in Molecular Neuroscience
  49. Longitudinal Alzheimer’s Degeneration Reflects the Spatial Topography of Cholinergic Basal Forebrain Projections
    Taylor W. Schmitz, Marieke Mur, Meghmik Aghourian, Marc‐André Bédard, R. Nathan Spreng · 2018 · Cell Reports
  50. Mouse models of frontotemporal dementia
    Erik D. Roberson · 2012 · Annals of Neurology
  51. Extracellular Vesicles Containing P301L Mutant Tau Accelerate Pathological Tau Phosphorylation and Oligomer Formation but Do Not Seed Mature Neurofibrillary Tangles in ALZ17 Mice
    Baker, Siân, Polanco, Juan Carlos, Götz, Jϋrgen · 2016 · Journal of Alzheimer's Disease
  52. Targeting tau: clinical trials and novel therapeutic approaches
    VandeVrede, Lawren, Boxer, Adam L., Polydoro, Manuela · 2020 · Neuroscience Letters
  53. Propagation of Tau Pathology: Integrating Insights From Postmortem and In Vivo Studies
    Thomas Vogels, Antoine Leuzy, Claudia Cicognola, Nicholas James Ashton, Tomáš Smolek, Michal Novák, Kaj Blennow, Henrik Zetterberg, Tomáš Hromádka, Norbert Žilka et al. · 2019 · Biological Psychiatry
  54. Lesions without symptoms: understanding resilience to Alzheimer disease neuropathological changes
    Gómez-Isla, Teresa, Frosch, Matthew P. · 2022 · Nature Reviews Neurology
  55. Optic neuropathies: characteristic features and mechanisms of retinal ganglion cell loss
    Yuyi You, Vivek Gupta, Jonathan C. Li, Alexander I. Klistorner, Stuart L. Graham · 2013 · Reviews in the Neurosciences
  56. The Role of Tau in Neurodegenerative Diseases and Its Potential as a Therapeutic Target
    Michael S. Wolfe · 2012 · Scientifica
  57. Sensitive Detection of Proteopathic Seeding Activity with FRET Flow Cytometry
    Jennifer L. Furman, Brandon B. Holmes, Marc I. Diamond · 2015 · Journal of Visualized Experiments
  58. Progressive Tau Accumulation in Alzheimer Disease: 2-Year Follow-up Study
    Cho, Hanna, Choi, Jae Yong, Lee, Hye Sun, Lee, Jae Hoon, Ryu, Young Hoon, Lee, Myung Sik, Jack, Clifford R., Lyoo, Chul Hyoung · 2019 · Journal of Nuclear Medicine
  59. Review: Prion‐like mechanisms of transactive response DNA binding protein of 43 kDa ( TDP ‐43) in amyotrophic lateral sclerosis ( ALS )
    Phillip Smethurst, Katie C. L. Sidle, John Hardy · 2014 · Neuropathology and Applied Neurobiology
  60. Secretion and Uptake of α-Synuclein Via Extracellular Vesicles in Cultured Cells
    Gabriel Gustafsson, Camilla Lööv, Emma Persson, Diana F. Lázaro, Shuko Takeda, Joakim J. E. Bergström, Anna Erlandsson, Dag Sehlin, Leonora Balaj, Bence György et al. · 2018 · Cellular and Molecular Neurobiology
  61. Astrocytes in Tauopathies
    Matthew J. Reid, Paula Beltran-Lobo, Louisa Johnson, Beatriz Gomez Perez‐Nievas, Wendy J. Noble · 2020 · Frontiers in Neurology
  62. Lipid Metabolism Influence on Neurodegenerative Disease Progression: Is the Vehicle as Important as the Cargo?
    Raja Estes, Bernice C. Lin, Arnav Khera, Marie Y. Davis · 2021 · Frontiers in Molecular Neuroscience
  63. Neurochemical mapping of the human hippocampus reveals perisynaptic matrix around functional synapses in Alzheimer’s disease.
    Lendvai, Dávid, Morawski, Markus, Négyessy, László, Gáti, Georgina, Jäger, Carsten, Baksa, Gábor, Glasz, Tibor, Attems, Johannes, Tanila, Heikki, Arendt, Thomas et al. · 2013 · Acta Neuropathologica
  64. In vivo imaging of tau pathology using multi-parametric quantitative MRI
    Wells, J.A., O'Callaghan, J.M., Holmes, H.E., Powell, N.M., Johnson, R.A., Siow, B., Torrealdea, F., Ismail, O., Walker-Samuel, S., Golay, X. et al. · 2015 · NeuroImage
  65. Prions and Protein Assemblies that Convey Biological Information in Health and Disease
    David W. Sanders, Sarah K. Kaufman, Brandon B. Holmes, Marc I. Diamond · 2016 · Neuron
  66. Cerebrovascular disease promotes tau pathology in Alzheimer’s disease
    Krystal K. Laing, Sabrina Simoes, Gloria Patricia Baena-Caldas, Patrick J. Lao, Milankumar Kothiya, Kay Chioma Igwe, Anthony G. Chesebro, Alexander Lee Houck, Lina Pedraza, Alejandro Ivan Hernandez et al. · 2020 · Brain Communications
  67. Overweight and obesity are associated with neuronal injury in the human cerebellum and hippocampus in young adults: a combined MRI, serum marker and gene expression study
    Karsten Mueller, Julia Sacher, Katrin Arélin, Štefan Holiga, J. Kratzsch, Arno Villringer, M. Schroeter · 2012 · Translational Psychiatry
  68. New Features about Tau Function and Dysfunction
    Miguel Medina, Félix Hernández, Jesús Ávila · 2016 · Biomolecules
  69. Amyloid and tau accumulate across distinct spatial networks and are differentially associated with brain connectivity
    Joana B. Pereira, Rik Ossenkoppele, Sebastian Palmqvist, Tor Olof Strandberg, Ruben A Smith, Eric Westman, Oskar Hansson · 2019 · eLife
  70. Tau oligomers derived from traumatic brain injury cause cognitive impairment and accelerate onset of pathology in htau mice
    Gerson, Julia, Castillo-Carranza, Diana L., Sengupta, Urmi, Bodani, Riddhi, Prough, Donald S., DeWitt, Douglas S., Hawkins, Bridget E., Kayed, Rakez · 2016 · Journal of Neurotrauma
  71. The Spread of Neurodegenerative Disease
    John Hardy, Tamás Révész · 2012 · New England Journal of Medicine
  72. Acyl-coenzyme A:cholesterol acyltransferase 1 blockage enhances autophagy in the neurons of triple transgenic Alzheimer's disease mouse and reduces human P301L-tau content at the presymptomatic stage
    Yohei Shibuya, Zhaoyang Niu, Elena Y. Bryleva, Brent T. Harris, Stephanie R Murphy, Alireza Kheirollah, Zachary D. Bowen, Catherine C.Y. Chang, Ta‐Yuan Chang · 2015 · Neurobiology of Aging
  73. Tau at the interface between neurodegeneration and neuroinflammation
    Didonna, Alessandro · 2020 · Genes & Immunity
  74. Relationships Between Tau and Glucose Metabolism Reflect Alzheimer’s Disease Pathology in Cognitively Normal Older Adults
    Jenna N. Adams, Samuel Neal Lockhart, Lexin Li, William J. Jagust · 2018 · Cerebral Cortex
  75. Amyloid Deposition Is Linked to Aberrant Entorhinal Activity among Cognitively Normal Older Adults
    Willem Huijbers, Elizabeth C. Mormino, Sarah E. Wigman, Andrew M. Ward, Patrizia Vannini, Donald G. McLaren, John Alex Becker, Aaron P. Schultz, Trey Hedden, Keith A. Johnson et al. · 2014 · Journal of Neuroscience
  76. Amyloid-β and Tau in Alzheimer’s disease: pathogenesis, mechanisms, and interplay
    Abdulkhaliq, Altaf A., Kim, Bonglee, Almoghrabi, Yousef M., Khan, Johra, Ajoolabady, Amir, Ren, Jun, Bahijri, Suhad, Tuomilehto, Jaakko, Borai, Anwar, Pratico, Domenico · 2026 · Cell Death & Disease
  77. Impact of Sleep Disturbances on Neurodegeneration: Insight from Studies in Animal Models
    J. Owen, S. Veasey · 2020 · Neurobiology of Disease
  78. Emerging Therapeutics for Alzheimer's Disease
    Karen Chiang, Edward H. Koo · 2014 · The Annual Review of Pharmacology and Toxicology
  79. Molecular imaging in dementia: Past, present, and future
    Robert Jr Laforce, Jean‐Paul Soucy, Leila Sellami, Caroline Dallaire‐Théroux, Francis Brunet, David Bergeron, Bruce L. Miller, Rik Ossenkoppele · 2018 · Alzheimer s & Dementia
  80. Invited review: Animal models of tauopathies and their implications for research/translation into the clinic
    Simon Dujardin, Morvane Colin, Luc Buée · 2014 · Neuropathology and Applied Neurobiology
  81. Stages and Conformations of the Tau Repeat Domain during Aggregation and Its Effect on Neuronal Toxicity
    Satish Kumar, Katharina Tepper, Senthilvelrajan Kaniyappan, Jacek Biernat, Susanne Wegmann, Eva‐Maria Mandelkow, Daniel J. Müller, Eckhard Mandelkow� · 2014 · Journal of Biological Chemistry
  82. RNA Binds to Tau Fibrils and Sustains Template-Assisted Growth
    Paul D. Dinkel, Michael R. Holden, Nadira Matin, Martin Margittai · 2015 · Biochemistry
  83. Tau-Driven Neuronal and Neurotrophic Dysfunction in a Mouse Model of Early Tauopathy
    Nadia Mazzaro, Erica Barini, Maria Grazia Spillantini, Michel Goedert, Paolo Medini, Laura Gasparini · 2016 · Journal of Neuroscience
  84. Recent Advances in the Study of Bipolar/Rod-Shaped Microglia and their Roles in Neurodegeneration
    Ngan Pan Bennett Au, Chi Him Eddie Ma · 2017 · Frontiers in Aging Neuroscience
  85. Tauopathies: Deciphering Disease Mechanisms to Develop Effective Therapies
    M. Catarina Silva, Stephen J. Haggarty · 2020 · International Journal of Molecular Sciences
  86. Melatonin attenuates impairments of structural hippocampal neuroplasticity in OXYS rats during active progression of A lzheimer's disease‐like pathology
    Natalia A. Stefanova, Kseniya Yi. Maksimova, Киселева Елена Владимировна, Ekaterina A. Rudnitskaya, Natalia A. Muraleva, Nataliya G. Kolosova · 2015 · Journal of Pineal Research
  87. Starvation and inhibition of lysosomal function increased tau secretion by primary cortical neurons
    Nguyen‐Vi Mohamed, Vanessa Plouffe, Gaudeline Rémillard‐Labrosse, Emmanuel Planel, Nicole M. Leclerc · 2014 · Scientific Reports
  88. Open questions for Alzheimer’s disease immunotherapy
    Todd Eliot Golde · 2014 · Alzheimer s Research & Therapy
  89. Recent Progress in Alzheimer’s Disease Research, Part 1: Pathology
    Francis T. Hane, Brenda Yasie Lee, Zoya Leonenko · 2017 · Journal of Alzheimer s Disease
  90. Hyperphosphorylated tau (p-tau) and drug discovery in the context of Alzheimer's disease and related tauopathies
    Kendall B. E. Moore, Ta-Jung Hung, Jessica S. Fortin · 2023 · Drug Discovery Today
  91. The Evolving Dialogue of Microglia and Neurons in Alzheimer’s Disease: Microglia as Necessary Transducers of Pathology
    Simon, E., Obst, J., Gomez-Nicola, D. · 2019 · Neuroscience
  92. Longitudinal tau-PET uptake and atrophy in atypical Alzheimer's disease
    Irene Sintini, Peter R. Martin, Jonathan Graff‐Radford, Matthew L. Senjem, Christopher G. Schwarz, Mary M. Machulda, Anthony J. Spychalla, Daniel A. Drubach, David S. Knopman, Ronald Carl Petersen et al. · 2019 · NeuroImage Clinical
  93. Origins of Alzheimerʼs disease
    Erik S. Musiek, David M. Holtzman · 2012 · Current Opinion in Neurology
  94. P301L tau expression affects glutamate release and clearance in the hippocampal trisynaptic pathway
    Holly C. Hunsberger, Carolyn C. Rudy, Seth R. Batten, Greg A. Gerhardt, Miranda Nicole Reed · 2014 · Journal of Neurochemistry
  95. Pathological concentration of zinc dramatically accelerates abnormal aggregation of full-length human Tau and thereby significantly increases Tau toxicity in neuronal cells
    Ji-Ying Hu, De-Lin Zhang, Xiaoling Liu, Xue-Shou Li, Xiaoqing Cheng, Jie Chen, Hai‐Ning Du, Yi Liang · 2016 · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease
  96. Fyn Kinase Controls Tau Aggregation In Vivo
    Adam Briner, Jürgen Götz, Juan Carlos Polanco · 2020 · Cell Reports
  97. Mutant Tau knock-in mice display frontotemporal dementia relevant behaviour and histopathology
    David J. Koss, Lianne Robinson, Benjamin D. Drever, Kaja Plucińska, Sandra Stoppelkamp, Peter Veselcic, Gernot Riedel, Bettina Platt · 2016 · Neurobiology of Disease
  98. Increased misfolding and truncation of tau in APP/PS1/tau transgenic mice compared to mutant tau mice
    Héraud, Céline, Goufak, Doris, Ando, Kunie, Leroy, Karelle, Suain, Valérie, Yilmaz, Zehra, De Decker, Robert, Authelet, Michèle, Laporte, Vincent, Octave, Jean-Noël et al. · 2014 · Neurobiology of Disease
  99. Tau prion-like propagation: state of the art and current challenges
    Dujardin, Simon, Hyman, Bradley T. · 2019 · Advances in Experimental Medicine and Biology
  100. Ubiquitin, Autophagy and Neurodegenerative Diseases
    Yoshihisa Watanabe, Katsutoshi Taguchi, Masaki Tanaka · 2020 · Cells